Biota completes new flu trial
31 July, 2008 by Dylan Bushell-EmblingPhase II trials of long-acting compound conclude, Phase III next
Innovation review extended
31 July, 2008 by Kate McDonaldDeadline for Innovation Review green paper extended by a month
ASCC board sacks Livesey
31 July, 2008 by Kate McDonaldStephen Livesey has "departed" the ASCC over difference with board
AtCor's pressure rises
30 July, 2008 by Dylan Bushell-EmblingExcellent sales results reported by AtCor
Lancet for Prana
30 July, 2008 by Dylan Bushell-EmblingLancet Neurology publishes Prana's PBT2 trial results
Oncaidia's best practice
30 July, 2008 by Dylan Bushell-EmblingOncaidia wins award Frost & Sullivan award for Apomab technology
Mayo specialist for Cytopia
30 July, 2008 by Dylan Bushell-EmblingCytopia appoints clinical trial chair
Pond scum and the biofuel revolution
29 July, 2008 by Staff WritersMurdoch Uni wins grant to research turning algae into energy
Heaves hit for Stirling
29 July, 2008 by Dylan Bushell-EmblingStirling wins patent for equine heaves treatment
Clinuvel granted orphan designation
29 July, 2008 by Dylan Bushell-EmblingClinuvel's CUV1647 granted orphan drug designation by US FDA
Tutti frutti for Kiwis
29 July, 2008 by Dylan Bushell-EmblingLarge EST library for kiwifruit published, fleshing out apples and pears
Life to appeal Federal Court decision
29 July, 2008 by Dylan Bushell-EmblingLife Therapeutics to appeal federal court decision preventing its planned share sale
LCT is US-bound
29 July, 2008 by Dylan Bushell-EmblingLiving Cell Technologies appoints new US-based CEO
CogState releases details of UBC agreement
29 July, 2008 by Dylan Bushell-EmblingParties will combine to launch a new product but will remain separate entities
Biotech: worst year on record
29 July, 2008 by Kate McDonaldFinal quarter of FY08 down again, year the worst on record: PwC
